Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by CIBC Asset Management Inc

CIBC Asset Management Inc lessened its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 5.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,148 shares of the company’s stock after selling 182 shares during the quarter. CIBC Asset Management Inc’s holdings in Prestige Consumer Healthcare were worth $217,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Covestor Ltd raised its stake in shares of Prestige Consumer Healthcare by 21.6% in the 1st quarter. Covestor Ltd now owns 834 shares of the company’s stock valued at $61,000 after acquiring an additional 148 shares during the period. Miller Howard Investments Inc. NY increased its stake in Prestige Consumer Healthcare by 2.2% during the 2nd quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company’s stock worth $534,000 after buying an additional 165 shares during the period. EverSource Wealth Advisors LLC increased its stake in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after buying an additional 208 shares during the period. Parallel Advisors LLC increased its stake in Prestige Consumer Healthcare by 42.5% during the 4th quarter. Parallel Advisors LLC now owns 714 shares of the company’s stock worth $44,000 after buying an additional 213 shares during the period. Finally, QRG Capital Management Inc. increased its stake in Prestige Consumer Healthcare by 4.7% during the 2nd quarter. QRG Capital Management Inc. now owns 5,397 shares of the company’s stock worth $372,000 after buying an additional 242 shares during the period. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Trading Down 2.3 %

NYSE PBH opened at $72.63 on Tuesday. Prestige Consumer Healthcare Inc. has a one year low of $56.34 and a one year high of $75.80. The company has a 50-day simple moving average of $70.38 and a 200-day simple moving average of $69.48. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23. The firm has a market capitalization of $3.60 billion, a PE ratio of 17.42, a price-to-earnings-growth ratio of 2.10 and a beta of 0.48.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, August 8th. The company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The firm had revenue of $267.10 million during the quarter, compared to analysts’ expectations of $260.54 million. During the same quarter in the prior year, the firm earned $1.06 EPS. Prestige Consumer Healthcare’s quarterly revenue was down 4.4% on a year-over-year basis. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms recently issued reports on PBH. Canaccord Genuity Group reaffirmed a “buy” rating and set a $80.00 price target on shares of Prestige Consumer Healthcare in a research note on Tuesday, May 21st. StockNews.com downgraded shares of Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. Finally, DA Davidson boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.75.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.